g them to replicate and to produce natural
growth factors and other gene expression products, which facilitate
reduction of the pain and edema associated with post-operative wound
healing in soft tissues. We believe Provant is effective, economical, and
easy-to-use.
About Regenesis Biomedical
Regenesis Biomedical, Inc. is a privately held medical technology
company focused on developing and marketing noninvasive regenerative
medicine products. Regenesis developed, patented, and now markets the
Provant Wound Therapy System. Our customers include health care facilities
and providers that serve patients with wounds being treated by acute care
hospitals, long- term acute care hospitals, skilled nursing facilities,
rehabilitation centers, home health care agencies, and wound care clinics.
Contact:
Regenesis Biomedical, Inc.
Media: Scott Robey, VP Marketing robey@regenesisbiomedical.com
Clinicians: Rick Isenberg, MD, VP Clinical Affairs
isenberg@regenesisbiomedical.com
Investors: Virginia Rybski, Acting President
rybski@regenesisbiomedical.com
http://www.regenesisbiomedical.com
480-970-4970
'/>"/>SOURCE Regenesis Biomedical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers2.
Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys3.
SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.4.
Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target5.
LifeNet Health(R) Unveils New Biomedical Spine Implant6.
MIT researcher addresses biomedical engineering challenges7.
mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical8.
Bookham to Enter Biomedical Illumination Market9.
ASH Holds a Special Symposium to Interest High School Students in Biomedical Research10.
New NIST mini-sensor may have biomedical and security applications11.
BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants